latest news releases from the newsroom
Dimond Kaplan & Rothstein, P.A.
Dimond Kaplan & Rothstein, P.A. Files FINRA Arbitration Claim Against Charles Schwab & Co., Inc. to Recover Schwab YieldPlus Investment Losses -- SWYSX, SWYPX
MIAMI, June 16, 2008 (PRIME NEWSWIRE) -- The securities law firm of Dimond Kaplan & Rothstein, P.A. (http://www.dkrpa.com or http://www.investmentfraud-lawyer.com) announced today that it filed a FINRA arbitration claim against Charles Schwab & Co., Inc. on behalf of a California investor who lost nearly $200,000 in the Schwab YieldPlus fund. The claim alleges causes of action for breach of contract, breach of fiduciary duty, negligence, negligent misrepresentations and omissions, and fraud.
Immunomedics' Pretargeting Method May Improve Radioimmunoimaging of Cancer
NEW ORLEANS, La., June 16, 2008 (PRIME NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported that pretargeting with a bispecific antibody (bsMAb) and a peptide labeled with gallium-68 (Ga-68), a positron emission tomography (PET) sensitive radioisotope, produced excellent images in a human colorectal cancer model.